Israeli startup VRPhysio matches virtual reality and physiotherapy to help patients exercise and speed up recovery; Hadasit and Israel’s BioLineRx are to develop a treatment for fatty liver disease, and much more.
In a landmark discovery, researchers at Tel Aviv University (TAU) have unraveled the metastatic mechanism of melanoma, the most aggressive of all skin cancers and may therefore have found a way to prevent it.
Israel’s Aspect Imaging develops small, affordable and innovative MRI scanners; Scientists at Israel’s Technion Institute have discovered that the placebo effect has validity, and much more.
Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its treatment for osteoarthritis pain and hypertension; the UK has approved the funding of patients receiving the pioneering melanoma treatment developed by an Israeli Professor, and much more.
One of my readers suggested that I write another anti-boycott article, so I just took excerpts from Israel’s positive news over the last 3 weeks and will let you make up your minds as to whether or not there is a boycott.